Latest news
As FDA Approves First-Ever mRNA Flu Vaccine For Older Adults, Past KFF Polling Showed Most In This Age Group Were Uncertain About the Technology’s Safety - Sierra Sun TimesSierra Sun Times · Sat, 08 Aug 2026 12:13:31 GMTaTyr Pharma Prioritizes Efzofitimod Program, Cuts Workforce 60% as FDA Feedback on Phase 3 Sarcoidosis Study Protocol Looms - Quiver QuantitativeQuiver Quantitative · Fri, 07 Aug 2026 20:10:00 GMTNRx Pharmaceuticals Shares Rise as FDA Completes Initial Review of Ketamine Product - citybizcitybiz · Fri, 07 Aug 2026 18:01:20 GMTNRx Pharma rises on FDA review of ketamine ANDA (NRXP:NASDAQ) - Seeking AlphaSeeking Alpha · Fri, 07 Aug 2026 17:08:38 GMTFDA reverses course with accelerated nod for Tudriqev in melanoma - thepharmaletter.comthepharmaletter.com · Fri, 07 Aug 2026 10:18:54 GMTThird time lucky for Replimune as FDA OKs melanoma drug - pharmaphorumpharmaphorum · Fri, 07 Aug 2026 09:50:13 GMTReplimune wins on third try as FDA clears Tudriqev for melanoma - FirstWord PHARMAFirstWord PHARMA · Fri, 07 Aug 2026 00:57:10 GMTMRNA Stock Gets a Shot in the Arm as FDA Approves Moderna Flu Vaccine - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 18:01:20 GMT